IMU is a leading force in expediting the development of cell therapy drugs. Through our state-of-the-art immune analytics platform, we tackle key challenges in the development process, including donor selection, product characterization, and patient stratification and monitoring. Our integrated approach ensures a streamlined and effective development process, facilitating the delivery of cutting-edge therapies to the appropr...
IMU is a leading force in expediting the development of cell therapy drugs. Through our state-of-the-art immune analytics platform, we tackle key challenges in the development process, including donor selection, product characterization, and patient stratification and monitoring. Our integrated approach ensures a streamlined and effective development process, facilitating the delivery of cutting-edge therapies to the appropriate patients. The IMU platform, known as CytAtlas™, is deployed across various health and disease contexts to propel translational research forward and hasten the drug development timeline.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.